| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 424.03M | 337.33M | 356.43M | 385.61M | 452.96M |
| Gross Profit | 89.03M | 66.21M | 155.22M | 84.28M | 41.86M |
| EBITDA | -7.56M | -34.18M | 73.97M | -34.07M | -47.26M |
| Net Income | -15.75M | -40.30M | 43.49M | -58.06M | -93.86M |
Balance Sheet | |||||
| Total Assets | 680.35M | 1.33B | 1.11B | 997.33M | 605.14M |
| Cash, Cash Equivalents and Short-Term Investments | 140.56M | 81.29M | 105.26M | 156.41M | 265.30M |
| Total Debt | 396.97M | 982.66M | 555.41M | 596.75M | 150.82M |
| Total Liabilities | 530.73M | 1.17B | 896.60M | 830.71M | 385.57M |
| Stockholders Equity | 149.22M | 165.69M | 205.55M | 162.07M | 219.57M |
Cash Flow | |||||
| Free Cash Flow | 95.06M | -12.00K | -93.56M | -68.83M | -1.23M |
| Operating Cash Flow | 102.68M | 1.43M | -88.95M | -68.70M | 3.74M |
| Investing Cash Flow | -10.41M | -11.79M | -4.59M | 7.86M | 7.64M |
| Financing Cash Flow | -38.38M | -18.20M | 48.30M | -47.86M | -15.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$2.25B | 1.98 | 18.23% | 12.15% | 13.76% | 25.01% | |
66 Neutral | HK$1.18B | 3.23 | 14.15% | 9.09% | 26.57% | -2.39% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | HK$1.47B | -13.79 | -68.32% | ― | 26.40% | -6.44% | |
52 Neutral | HK$1.81B | 4.80 | 9.56% | ― | 96.63% | ― | |
45 Neutral | HK$972.06M | 707.71 | -7.49% | ― | -16.73% | 65.63% | |
41 Neutral | HK$388.18M | -236.90 | -8.55% | ― | -37.55% | -1727.78% |